Oncodesign Precision Medicine
Oncodesign Precision Medicine Société anonyme, a biopharmaceutical company, engages in the precision medicine business. The company's pipeline includes OPM-101, a potentially inhibitor of the RIPK2 target, which is in Phase 1 clinical trial for the treatment of inflammatory bo...
Social media
Oncodesign Precision Medicine Logo
About Oncodesign Precision Medicine
Oncodesign Precision Medicine (OPM) is a biopharmaceutical company. The Company provides therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution. OPM serves patients, clinicians, and service provider in France.
Address
18 rue Jean Mazen,
Dijon, 21000
France
Year founded
2020
Number of employees
0-100
Report inaccurate data
Request an update to help us keep the brand up-to-date.
